Home Haisco's Innovative Non-Opioid Analgesic HSK51155 Tablet Receives NMPA Clinical Trial Acceptance; Global Exclusive License with AbbVie Previously Secured

Haisco's Innovative Non-Opioid Analgesic HSK51155 Tablet Receives NMPA Clinical Trial Acceptance; Global Exclusive License with AbbVie Previously Secured

Jun 09, 2026 16:21 CST Updated 17:07
Haisco

New Drug Research and Development, Production, and Sales